Missing/wrong data?
Log in to edit
Cost-effectiveness of ibrutinib as first-line therapy for chronic lymphocytic leukemia in older adults without deletion 17p
Author/s
author: Jeremy Goldhaber-Fiebert, Douglas K Owens
Work details
Publication date
August 14, 2018
-
-
Language
English
Copyright status
Copyright status information is not available for this work. The copyright status depends on the jurisdiction, the author's date of death and the date the work was created or published.
To learn more about copyright terms in different countries, visit the countries and terms page.